Henagliflozin Delays the Progress of Diabetic Nephropathy Via Regulates Gut-Renal Axis

NCT06031389 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

Diabetic Nephropathies

Interventions

DRUG: Henagliflozin
DRUG: Placebo

Sponsor

Qianfoshan Hospital